Mogo Moringa LLC Recalls Select Moringa Capsule Lots Over Possible Salmonella
The Story
Mogo Moringa LLC, based in Saint Louis, Missouri, is voluntarily recalling specific lots of its Mogo Moringa Capsules after discussions with the U.S. Food and Drug Administration (FDA) regarding a possible Salmonella contamination concern. The company stated that independent third‑party laboratory testing on retained samples from the affected lots found no Salmonella, and the recall is proceeding as a precaution in coordination with the FDA.
Key Facts
- Mogo Moringa LLC voluntarily recalled select lots of Mogo Moringa Oleifera Capsules on May 25, 2026.
- The recall was initiated after discussions with the FDA over a possible Salmonella contamination concern.
- Affected lots are Lot 15525AA (Exp 06/2027) and Lot 00926AA (Exp 01/2028).
- The product is packaged in a white plastic bottle and sold online through authorized channels.
- Independent third‑party lab testing on retained samples from the affected lots detected no Salmonella.
- No other lots or Mogo Moringa LLC products are included in the recall.
- The company recommended that consumers not use product from the affected lots.
Conflicting Reports
No conflicting reports identified in the source article.
Still Unclear
No open questions identified in the source article.
Misconceptions
No widespread misconceptions addressed in the source article.
Key Figures
- Mogo Moringa LLC (company, Saint Louis, Missouri)
- U.S. Food and Drug Administration (FDA)
Sources: CDC
